NTRB · Nutriband Inc.
Nutriband Inc (NTRB)
What's happening
- NTRB is up 7.48% today, trading at $4.60. — Live quote
- Volume today (254) is well below its 3-month average of 15,290. (Finnhub fundamentals)
- Reports earnings on 2026-09-07, 4 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $-0.08 actual vs. $-1.93 estimated (+95.9%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Aggregate ratings for 2026-09-01 (7 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
Earnings Trends (Quarterly EPS Actual vs Estimate)
Valuation Measures & Ratios
Quarterly history (5 periods)
| Measure | Apr '26 | Oct '25 | Jul '25 | Apr '25 | Oct '24 |
|---|---|---|---|---|---|
| Market cap | $49.1M | $80.1M | $6.9M | $80.8M | $69.8M |
| P/E | -5.77 | -9.29 | -1.06 | -12.71 | -10.37 |
| Price/Sales | 23.71 | 35.11 | 2.88 | 37.32 | 36.25 |
| Price/Book | 8.19 | 10.61 | 0.81 | 15.83 | 6.21 |
| EV/Revenue | 21.77 | 32.78 | -0.06 | 35.95 | 33.29 |
| ROE | -141.96% | -114.24% | -76.02% | -124.53% | -59.89% |
| ROA | -123.38% | -102.44% | -63.45% | -103.30% | -53.62% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E and PEG aren't shown here — both need historical analyst-consensus estimates, which no free source provides; see the current-period figures above instead.
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-08-14. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Signals describe daily price patterns—not the company’s value and not a recommendation to buy or sell. Read several together; no single indicator predicts what happens next. “Overbought” and “oversold” are conditions, not promises of a reversal.
Indicators None active
Free IEX historical data only goes back to ~2021 — 5Y/Full show whatever's actually available, not a promise of that much history. Indicators are computed client-side from these same price bars; earnings markers ("E") come from Finnhub's free tier (~last 4 quarters + next upcoming) — older quarters aren't available. The move-highlight dots are a heuristic (|% change| vs rolling volatility) with a best-effort headline lookup, not a claim of causation.
Peer and sector context
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 8-K, filed 2026-06-22; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -35.1% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is -448.4%. Finnhub fundamentals ↗
- Trailing 52-week price return is -29.6%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on NTRB
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Apr '26 | Oct '25 | Jul '25 | Apr '25 | Oct '24 | Jul '24 | Apr '24 | Oct '23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $433.4K | $346.1K | $622.5K | $667.4K | $645.8K | $442.8K | $408.5K | $427.8K |
| Gross profit | — | $68.5K | $156.9K | $252.0K | $191.0K | $101.6K | $164.8K | $159.7K |
| Operating income | -$1.3M | -$3.9M | -$2.0M | -$1.4M | -$1.4M | -$1.4M | -$1.9M | -$1.7M |
| Net income | -$1.2M | -$3.9M | -$2.0M | -$1.4M | -$1.4M | -$1.7M | -$1.9M | -$1.8M |
| EPS (diluted) | $-0.10 | $-0.32 | $-2.12 | $-0.12 | $-0.12 | $-0.15 | $-0.21 | $-0.22 |
| EPS (basic) | $-0.10 | $-0.32 | $-2.12 | $-0.12 | $-0.12 | $-0.15 | $-0.21 | $-0.22 |
| Operating margin | -$289 | -$1.1K | -$322 | -$212 | -$221 | -$318 | -$463 | -$403 |
| Net margin | -$287 | -$1.1K | -$321 | -$208 | -$211 | -$385 | -$465 | -$411 |
Balance sheet
| Line item | Apr '26 | Jan '26 | Oct '25 | Jul '25 | Apr '25 | Jan '25 | Oct '24 | Jul '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $6.9M | $7.5M | $8.4M | $10.2M | $6.2M | $7.5M | $12.5M | $13.6M |
| Total liabilities | $902.3K | $868.4K | $870.2K | $1.7M | $1.0M | $1.0M | $1.3M | $1.2M |
| Stockholders' equity | $6.0M | $6.7M | $7.5M | $8.5M | $5.1M | $6.4M | $11.2M | $12.5M |
| Total current assets | $4.4M | $5.0M | $5.8M | $7.5M | $3.4M | $4.8M | $6.2M | $7.2M |
| Total current liabilities | $832.1K | $784.3K | $772.5K | $1.6M | $925.1K | $982.8K | $1.2M | $1.1M |
| Cash & equivalents | $4.0M | $4.6M | $5.3M | $7.0M | $3.0M | $4.3M | $5.7M | $6.8M |
| Accounts receivable | $2.6K | $118.4K | $147.6K | $160.8K | $94.1K | $73.8K | $109.6K | $68.0K |
| Inventory | $121.5K | $118.0K | $136.0K | $138.0K | $215.3K | $212.0K | $168.3K | $223.9K |
| Property, plant & equipment | $548.2K | $567.3K | $588.0K | $615.9K | $658.1K | $695.1K | $739.6K | $737.5K |
| Goodwill | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $5.0M | $5.0M |
| Intangible assets | $185.3K | $200.4K | $215.6K | $230.8K | $245.9K | $261.1K | $582.4K | $610.7K |
| Deferred revenue (current) | $30.4K | $120.3K | $7.0K | $19.4K | $44.7K | $155.9K | $218.9K | $179.6K |
| Short-term debt | — | — | — | — | — | — | — | — |
| Long-term debt | — | — | — | — | — | — | — | — |
| Common stock & paid-in capital | $12.2K | $12.2K | $12.2K | $12.0K | $11.1K | $11.1K | $11.1K | $11.1K |
| Retained earnings | -$47.9M | -$46.7M | -$45.7M | -$41.9M | -$39.9M | -$38.5M | -$32.9M | -$31.6M |
| Accumulated other comprehensive income (loss) | -$304 | -$304 | -$304 | -$304 | -$304 | -$304 | -$304 | -$304 |
Cash flow
| Line item | Apr '26 | Jan '26 | Oct '25 | Jul '25 | Apr '25 | Jan '25 | Oct '24 | Jul '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$563.1K | -$731.8K | -$1.8M | -$1.3M | -$1.3M | -$1.2M | -$1.0M | -$1.5M |
| Investing cash flow | — | $0 | $0 | $0 | -$5.3K | $0 | -$47.0K | -$38.9K |
| Financing cash flow | -$5.6K | -$5.5K | $69.6K | $5.3M | -$5.3K | -$147.2K | -$5.2K | -$5.1K |
| Free cash flow | — | -$731.8K | -$1.8M | -$1.3M | -$1.3M | -$1.2M | -$1.1M | -$1.6M |
| Capital expenditures | — | $0 | $0 | $0 | $5.3K | $0 | $47.0K | $38.9K |
| Depreciation & amortization | — | — | — | — | — | — | $73.1K | $69.9K |
| Share-based compensation | $552.5K | $98.5K | $2.5M | — | — | $855.6K | $0 | $130.4K |
| Change in accounts receivable | -$115.8K | -$29.2K | -$13.2K | $66.7K | $20.3K | -$35.8K | $41.6K | -$17.1K |
| Change in inventory | $3.5K | -$18.0K | -$2.0K | -$77.3K | $3.3K | $43.7K | -$55.6K | $53.8K |
| Debt issued | — | — | — | — | — | — | — | — |
| Debt repaid | — | — | — | — | — | — | — | — |
Income statement
| Line item | Jan '26 | Jan '25 | Jan '24 | Jan '23 | Jan '22 |
|---|---|---|---|---|---|
| Revenue | $2.0M | $2.1M | $2.1M | $2.1M | $1.4M |
| Gross profit | $566.3K | $743.3K | $862.1K | $750.4K | $554.3K |
| Operating income | -$8.3M | -$10.3M | -$4.9M | -$4.5M | -$6.1M |
| Net income | -$8.2M | -$10.5M | -$5.5M | -$4.5M | -$6.2M |
| EPS (diluted) | $-2.58 | $-0.99 | $-0.69 | $-0.53 | $-0.80 |
| EPS (basic) | $-2.58 | $-0.99 | $-0.69 | $-0.53 | $-0.80 |
| Operating margin | -$408 | -$481 | -$234 | -$215 | -$430 |
| Net margin | -$404 | -$490 | -$263 | -$216 | -$434 |
Balance sheet
| Line item | Jan '26 | Jan '25 | Jan '24 | Jan '23 | Jan '22 |
|---|---|---|---|---|---|
| Total assets | $7.5M | $7.5M | $7.5M | $9.5M | $12.7M |
| Total liabilities | $868.4K | $1.0M | $1.1M | $883.4K | $880.4K |
| Stockholders' equity | $6.7M | $6.4M | $6.4M | $8.6M | $11.9M |
| Total current assets | $5.0M | $4.8M | $1.0M | $2.7M | $5.5M |
| Total current liabilities | $784.3K | $982.8K | $999.1K | $748.6K | $779.3K |
| Cash & equivalents | $4.6M | $4.3M | $492.9K | $2.0M | $4.9M |
| Accounts receivable | $118.4K | $73.8K | $148.6K | $113.0K | $71.4K |
| Inventory | $118.0K | $212.0K | $168.6K | $229.3K | $131.6K |
| Property, plant & equipment | $567.3K | $695.1K | $774.9K | $897.7K | $979.3K |
| Goodwill | $1.7M | $1.7M | $5.0M | $5.0M | $5.3M |
| Intangible assets | $200.4K | $261.1K | $667.3K | $780.4K | $926.9K |
| Deferred revenue (current) | $120.3K | $155.9K | $157.5K | — | — |
| Short-term debt | — | — | — | — | — |
| Long-term debt | — | — | — | — | — |
| Common stock & paid-in capital | $12.2K | $11.1K | $8.9K | $7.8K | $9.2K |
| Retained earnings | -$46.7M | -$38.5M | -$28.0M | -$22.5M | -$18.0M |
| Accumulated other comprehensive income (loss) | -$304 | -$304 | -$304 | -$304 | -$304 |
Cash flow
| Line item | Jan '26 | Jan '25 | Jan '24 | Jan '23 | Jan '22 |
|---|---|---|---|---|---|
| Operating cash flow | -$5.1M | -$4.6M | -$3.5M | -$3.0M | -$2.8M |
| Investing cash flow | -$5.3K | -$92.0K | -$51.8K | -$79.3K | -$81.6K |
| Financing cash flow | $5.4M | $8.5M | $2.1M | $160.1K | $7.6M |
| Free cash flow | -$5.1M | -$4.7M | -$3.6M | -$3.1M | -$2.9M |
| Capital expenditures | $5.3K | $92.0K | $51.8K | $79.3K | $81.6K |
| Depreciation & amortization | — | — | $287.7K | $330.1K | $308.7K |
| Share-based compensation | $2.6M | $1.4M | $499.9K | $732.1K | $365.0K |
| Change in accounts receivable | $44.6K | -$74.8K | $154.0K | $41.7K | -$43.0K |
| Change in inventory | -$94.1K | $43.4K | -$60.7K | $97.7K | $78.8K |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding NTRB as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-09-03 11:48 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-06-22 | 8-K | 2026-06-01 | View on SEC.gov → |
| 2026-06-11 | 10-Q | 2026-04-30 | View on SEC.gov → |
| 2026-04-29 | 10-K | 2026-01-31 | View on SEC.gov → |
| 2026-04-07 | 8-K | 2026-03-30 | View on SEC.gov → |
| 2026-02-13 | 8-K | 2026-02-13 | View on SEC.gov → |
| 2026-02-03 | 8-K | 2026-01-24 | View on SEC.gov → |
| 2025-12-30 | 8-K | 2025-12-30 | View on SEC.gov → |
| 2025-12-11 | 10-Q | 2025-10-31 | View on SEC.gov → |
| 2025-10-28 | 8-K | 2025-10-28 | View on SEC.gov → |
| 2025-09-09 | 10-Q | 2025-07-31 | View on SEC.gov → |
| 2025-09-03 | 8-K | 2025-02-01 | View on SEC.gov → |
| 2025-08-07 | 8-K | 2025-08-05 | View on SEC.gov → |
Recent news
Headlines about NTRB (Nutriband Inc.). Links open the publisher — we don’t host full articles.
-
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 2026-08-24 -
Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight
Yahoo Finance · 2026-08-13 -
Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference
Yahoo Finance · 2026-05-15 -
Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast
Yahoo Finance · 2026-04-22 -
Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch
Yahoo Finance · 2026-03-30 -
Nutriband AI Kinesiology Tapes approved for Distribution and Sale in Costa Rica
Yahoo Finance · 2026-03-18 -
Nutriband Signs Exclusive Distribution Agreement with Innomedica for AVERSA Fentanyl and all Sports Tape products for Costa Rica
Yahoo Finance · 2026-02-17 -
The past five years for Nutriband (NASDAQ:NTRB) investors has not been profitable
Yahoo Finance · 2026-01-29
No headlines in this category right now — try “All”.